Clinical trialNCT05925842UnknownObservational

Clinical and Molecular Characterization of Axial Psoriatic Arthritis (PsA), A Pilot Study

SponsorGroup for Research and Assessment of Psoriasis and Psoriatic ArthritisEnrollment40Psoriatic Arthritis

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Objectives: To identify a candidate set of biomarkers specific to AxPsA. Overview: Clinical and imaging characterization of PsA patients will be combined with extensive molecular assessment of both liquid and tissue compartments to identify biomarkers which differentiate PsA patients with and without axial involvement

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Oliver Fitzgerald, MD
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis
Study Director
clinicaltrials.gov ↗
Philip Mease, MD
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗
Vinod Chandran, MD
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of California San Diego
La Jolla, California, United States
Seattle Rheumatology Associates
Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 25 Jan 2023
Primary completion: 29 Feb 2024
Completion: 30 Sept 2024
Last update posted: 29 Jun 2023
Registered enrollment: 40
Registry id: NCT05925842

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.